The role of cutaneous T-cell attracting chemokine in the development of different phenotypes of atopic dermatitis in children

The goal of this study was to detect the risk of developing different atopic dermatitis (AD) phenotypes in children (isolated or combined with other comorbid atopic diseases (AtD)) depending on serum concentrations of cutaneous T-cell attracting chemokine (CTACK)/CCL27. The main group comprised 37 c...

Full description

Saved in:
Bibliographic Details
Main Authors: V.O. Dytiatkovsky, O.Є. Abaturov, N.V. Naumenko, O.O. Alifirenko, I.A. Filatova, S.M. Taran
Format: Article
Language:English
Published: Dnipro State Medical University 2021-09-01
Series:Medičnì Perspektivi
Subjects:
Online Access:http://journals.uran.ua/index.php/2307-0404/article/view/241933
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846146832900554752
author V.O. Dytiatkovsky
O.Є. Abaturov
N.V. Naumenko
O.O. Alifirenko
I.A. Filatova
S.M. Taran
author_facet V.O. Dytiatkovsky
O.Є. Abaturov
N.V. Naumenko
O.O. Alifirenko
I.A. Filatova
S.M. Taran
author_sort V.O. Dytiatkovsky
collection DOAJ
description The goal of this study was to detect the risk of developing different atopic dermatitis (AD) phenotypes in children (isolated or combined with other comorbid atopic diseases (AtD)) depending on serum concentrations of cutaneous T-cell attracting chemokine (CTACK)/CCL27. The main group comprised 37 children aged 3 to 18 years old suffering from different AD phenotypes – isolated (18 patients) and combined with comorbid AtD – AR/ARC and/or bronchial asthma (21 patients). The control group comprised 47 children aged 3 to 18 years old, suffering from diseases of the gastrointestinal tract (GIT). Serum CTACK/CCL 27 concentrations were detected in all children. In the full main group, the average level of CTACK/CCL27 was significantly higher compared to the patients of the control group: 4403.6 pg/ml (95% CI: 3726.2; 5148.7, p<0.001) and 3495.9 pg/ml (95% CI: 3197.8; 4186.8, p<0.001), respectively. Mean serum CTACK/CCL27 levels in patients of the main group with different AD phenotypes were higher than those in the full main group: with isolated AD – 4549.4 pg/ml (LQ; HQ: 3923.5; 5175.2, p<0.05), with AD associated with other AtD – 5116.6 pg/ml (LQ, HQ: 4062.8; 6170.5, p<0.05). In phenotypes of overall and isolated AD, the cut-off value of serum CTACK/ CCL27 is 3586.5 pg/ml (76.9% and 77.8%, respectively, and 38.3% in the control group). The risk of development at this concentration is 5.37 (95% CI: 2.05; 14.07, p<0.001) for the total AD phenotype and 5.64 (95% 1.56; 20.32, p<0.05) for the isolated AD phenotype. In AD phenotype combined with comorbid AtD, the cut-off value of serum CTACK/CCL27 is 4308.8 pg/ml (66.7% of the main and 21.3% in the control group). The risk of developing this AD phenotype at this concentration is 7.40 (95% CI: 2.30; 23.76, p<0.001). Serum CTACK/CCL27 levels are the reliable biomarker of the risk for developing different AD phenotypes in children. In the serum level of CTACK/CCL27=3658.5 pg/ml, the significant risk of developing total AD phenotype is 5.37, and isolated – AD=5.64. In the serum concentration of CTACK/CCL27=4308.8 pg/ml, the significant risk of developing AD phenotype combined with comorbid AtD is 7.40.
format Article
id doaj-art-92180a1296284403b731a432d972df2f
institution Kabale University
issn 2307-0404
language English
publishDate 2021-09-01
publisher Dnipro State Medical University
record_format Article
series Medičnì Perspektivi
spelling doaj-art-92180a1296284403b731a432d972df2f2024-12-02T01:10:19ZengDnipro State Medical UniversityMedičnì Perspektivi2307-04042021-09-01263394610.26641/2307-0404.2021.3.241933279686The role of cutaneous T-cell attracting chemokine in the development of different phenotypes of atopic dermatitis in childrenV.O. Dytiatkovskyhttps://orcid.org/0000-0002-8508-5562O.Є. Abaturovhttps://orcid.org/0000-0001-6291-5386N.V. NaumenkoO.O. AlifirenkoI.A. FilatovaS.M. TaranThe goal of this study was to detect the risk of developing different atopic dermatitis (AD) phenotypes in children (isolated or combined with other comorbid atopic diseases (AtD)) depending on serum concentrations of cutaneous T-cell attracting chemokine (CTACK)/CCL27. The main group comprised 37 children aged 3 to 18 years old suffering from different AD phenotypes – isolated (18 patients) and combined with comorbid AtD – AR/ARC and/or bronchial asthma (21 patients). The control group comprised 47 children aged 3 to 18 years old, suffering from diseases of the gastrointestinal tract (GIT). Serum CTACK/CCL 27 concentrations were detected in all children. In the full main group, the average level of CTACK/CCL27 was significantly higher compared to the patients of the control group: 4403.6 pg/ml (95% CI: 3726.2; 5148.7, p<0.001) and 3495.9 pg/ml (95% CI: 3197.8; 4186.8, p<0.001), respectively. Mean serum CTACK/CCL27 levels in patients of the main group with different AD phenotypes were higher than those in the full main group: with isolated AD – 4549.4 pg/ml (LQ; HQ: 3923.5; 5175.2, p<0.05), with AD associated with other AtD – 5116.6 pg/ml (LQ, HQ: 4062.8; 6170.5, p<0.05). In phenotypes of overall and isolated AD, the cut-off value of serum CTACK/ CCL27 is 3586.5 pg/ml (76.9% and 77.8%, respectively, and 38.3% in the control group). The risk of development at this concentration is 5.37 (95% CI: 2.05; 14.07, p<0.001) for the total AD phenotype and 5.64 (95% 1.56; 20.32, p<0.05) for the isolated AD phenotype. In AD phenotype combined with comorbid AtD, the cut-off value of serum CTACK/CCL27 is 4308.8 pg/ml (66.7% of the main and 21.3% in the control group). The risk of developing this AD phenotype at this concentration is 7.40 (95% CI: 2.30; 23.76, p<0.001). Serum CTACK/CCL27 levels are the reliable biomarker of the risk for developing different AD phenotypes in children. In the serum level of CTACK/CCL27=3658.5 pg/ml, the significant risk of developing total AD phenotype is 5.37, and isolated – AD=5.64. In the serum concentration of CTACK/CCL27=4308.8 pg/ml, the significant risk of developing AD phenotype combined with comorbid AtD is 7.40.http://journals.uran.ua/index.php/2307-0404/article/view/241933atopic dermatitischildrenphenotypesriskcutaneous t-cell attracting chemokine
spellingShingle V.O. Dytiatkovsky
O.Є. Abaturov
N.V. Naumenko
O.O. Alifirenko
I.A. Filatova
S.M. Taran
The role of cutaneous T-cell attracting chemokine in the development of different phenotypes of atopic dermatitis in children
Medičnì Perspektivi
atopic dermatitis
children
phenotypes
risk
cutaneous t-cell attracting chemokine
title The role of cutaneous T-cell attracting chemokine in the development of different phenotypes of atopic dermatitis in children
title_full The role of cutaneous T-cell attracting chemokine in the development of different phenotypes of atopic dermatitis in children
title_fullStr The role of cutaneous T-cell attracting chemokine in the development of different phenotypes of atopic dermatitis in children
title_full_unstemmed The role of cutaneous T-cell attracting chemokine in the development of different phenotypes of atopic dermatitis in children
title_short The role of cutaneous T-cell attracting chemokine in the development of different phenotypes of atopic dermatitis in children
title_sort role of cutaneous t cell attracting chemokine in the development of different phenotypes of atopic dermatitis in children
topic atopic dermatitis
children
phenotypes
risk
cutaneous t-cell attracting chemokine
url http://journals.uran.ua/index.php/2307-0404/article/view/241933
work_keys_str_mv AT vodytiatkovsky theroleofcutaneoustcellattractingchemokineinthedevelopmentofdifferentphenotypesofatopicdermatitisinchildren
AT oêabaturov theroleofcutaneoustcellattractingchemokineinthedevelopmentofdifferentphenotypesofatopicdermatitisinchildren
AT nvnaumenko theroleofcutaneoustcellattractingchemokineinthedevelopmentofdifferentphenotypesofatopicdermatitisinchildren
AT ooalifirenko theroleofcutaneoustcellattractingchemokineinthedevelopmentofdifferentphenotypesofatopicdermatitisinchildren
AT iafilatova theroleofcutaneoustcellattractingchemokineinthedevelopmentofdifferentphenotypesofatopicdermatitisinchildren
AT smtaran theroleofcutaneoustcellattractingchemokineinthedevelopmentofdifferentphenotypesofatopicdermatitisinchildren
AT vodytiatkovsky roleofcutaneoustcellattractingchemokineinthedevelopmentofdifferentphenotypesofatopicdermatitisinchildren
AT oêabaturov roleofcutaneoustcellattractingchemokineinthedevelopmentofdifferentphenotypesofatopicdermatitisinchildren
AT nvnaumenko roleofcutaneoustcellattractingchemokineinthedevelopmentofdifferentphenotypesofatopicdermatitisinchildren
AT ooalifirenko roleofcutaneoustcellattractingchemokineinthedevelopmentofdifferentphenotypesofatopicdermatitisinchildren
AT iafilatova roleofcutaneoustcellattractingchemokineinthedevelopmentofdifferentphenotypesofatopicdermatitisinchildren
AT smtaran roleofcutaneoustcellattractingchemokineinthedevelopmentofdifferentphenotypesofatopicdermatitisinchildren